deoxycorticosterone


Also found in: Medical, Acronyms, Encyclopedia, Wikipedia.
Related to deoxycorticosterone: Desoxycorticosterone

de·ox·y·cor·ti·cos·ter·one

 (dē-ŏk′sē-kôr′tĭ-kŏs′tə-rōn′)
n.
A steroid hormone, C21H30O3, secreted by the adrenal cortex or produced synthetically and formerly used to treat adrenal insufficiency.

deoxycorticosterone

(diːˌɒksɪˌkɔːtɪkəʊˈstɪərəʊn) or

deoxycortone

n
(Biochemistry) a corticosteroid hormone important in maintaining sodium and water balance in the body

de•ox•y•cor•ti•cos•ter•one

(diˌɒk sɪˌkɔr tɪˈkɒs təˌroʊn, -ˌkoʊ stəˈroʊn)

n.
a steroid hormone, C21H30O3, secreted by the adrenal cortex, related to corticosterone, and involved in water and electrolyte balance.
Translations

de·ox·y·cor·ti·co·ster·one

n. desoxicorticosterona, hormona producida en la corteza de las glándulas suprarrenales de efecto marcado en el metabolismo del agua y los electrólitos.
Mentioned in ?
References in periodicals archive ?
Increased ACTH causes hypokalemia, fluid retention, and hypertension as a consequence of deoxycorticosterone excess.
Niemann et al., "Deficiency of the interleukin 17/23 axis accelerates renal injury in mice with deoxycorticosterone acetate+angiotensin ii-induced hypertension," Hypertension, vol.
For instance, red wine polyphenols were reported to improve endothelial function and normalise blood pressure in NO-deficient hypertensive rats [14], in spontaneously hypertensive rats [15] and deoxycorticosterone acetate- (DOCA-) salt-induced hypertensive rats [16].
Khalid, "Effects of naloxone, glycyrrhizic acid, dexamethasone and deoxycorticosterone in repetitive stress," Clinical and Experimental Pharmacology and Physiology, vol.
In contrast to treatment with dexamethasone and testosterone, treatment with pure mineralocorticoid deoxycorticosterone acetate did not suppress the long QT phenotype.
Typical characteristics of women with the lack of 17OH are primary amenorrhea, high levels of FSH, LH, progesterone, deoxycorticosterone, hypertension and hyperpotassium alkalosis.
Table 1: Results of hormonal evaluation Patient's Female reference range value (follicular phase) Luteinizing hormone 56 1.9-9.2 U/L Follicle-stimulating hormone 145 3.5-9.2 U/L Estradiol <9.0 18-147 pg/mL Testosterone <0.02 0.084-0.481 ng/mL Dehydroepiandrosterone sulfate <2.5 98.8-340 [micro]g/dL Progesterone 5.8 0.25-0.54 ng/mL 17-OH progesterone <10 20-100 ng/dL Cortisol 0.9 5.4-28.7 [micro]g/dL Adrenocorticotropic hormone 185 6-76 pg/mL Deoxycorticosterone 54 2-19 ng/dL Aldosterone (supine) 0.5 2-9 ng/dL Plasma renin activity (supine) 0.1 0.2-1.6 ng/mL/h Anti-Mullerian hormone <0.2 For female: 1-10 ng/mL For male: 0.7-20 ng/mL
Protection against deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy.
Methods: Hypertension was induced in mice by surgical removal of a kidney and by subcutaneous administration of a pellet with deoxycorticosterone. Vasodilatation was measured in mesenteric arteries with a wire myograph.
In adrenals, Pcan be converted either into deoxycorticosterone under the control of 21-hydroxylase or 17-OHP by 17, 20 lyase.
Malignant hypertension resulting from deoxycorticosterone acetate and salt excess.
It addresses the prevalence and risk; the measurement of blood pressure; primary hypertension pathogenesis, natural history, and evaluation; the management of hypertension; treatment through lifestyle modifications and drug therapy; hypertensive emergencies; renal parenchymal and renovascular hypertension; primary aldosteronism; pheochromocytoma; hypertension induced by cortisol or deoxycorticosterone; other forms of hypertension; and hypertension in pregnancy, childhood, and adolescence and in the context of the birth control pill.